Emerald Advisers, LLC Abb Vie Inc. Transaction History

Emerald Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $290,262 - $371,023	-4,418 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $114,782 - $127,602	1,291 Added 41.29%	4,418 $418,000
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $280,742 - $332,181	3,127 New	3,127 $290,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.